BCEN Unveils New Mission, Vision And Values And Prepares To Celebrate Certified Nurses Day
News provided by
Share this article
Share this article
OAK BROOK, Ill., March 3, 2021 /PRNewswire/ The Board of Certification for Emergency Nursing (BCEN), the benchmark for board certification across the emergency nursing spectrum, today unveiled its new mission, vision and values as it prepares to honor the clinical excellence, professionalism and leadership of BCEN-certified emergency, trauma and transport nurses during international Certified Nurses Day celebrations later this month.
In 2020, BCEN substantially expanded its professional development and learning footprint with the introduction of the BCEN EDvantage certificate program and the BCEN Learn continuing education platform.
BCEN Unveils New Mission, Vision And Values And Prepares To Celebrate Certified Nurses Day
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
New Nursing Survey from ABNS Finds RNs Have Wide Range of Specialty Certification Options
prweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prweb.com Daily Mail and Mail on Sunday newspapers.
®, the only FDA-cleared device platform indicated to reduce blood culture contamination
1 – today announced that unprecedented Steripath clinical study results were presented to the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB).
Lucy S. Tompkins, MD, Ph.D., a professor and infectious diseases, microbiology and epidemiology expert at Stanford Health Care, presented Steripath
® Gen2 Initial Specimen Diversion Device
® (ISDD
®) phase-one study results at the PACCARB meeting in Washington, DC demonstrating unmatched reductions to blood culture contamination and false-positive central line-associated bloodstream infection (CLABSI) rates. What was even more clinically significant is that a 0.0% contamination rate and 0.0% false-positive CLABSI rate were maintained across over 11,000 blood cultures when Steripath was used throughout the course of the 10-month total trial period, continued Dr. Tompkins